We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus.
- Authors
San-Juan, Rafael; Viedma, Esther; Chaves, Fernando; Lalueza, Antonio; Fortún, Jesús; Loza, Elena; Pujol, Miquel; Ardanuy, Carmen; Morales, Isabel; de Cueto, Marina; Resino-Foz, Elena; Morales-Cartagena, Alejandra; Rico, Alicia; Romero, María P.; Orellana, María Ángeles; López-Medrano, Francisco; Fernández-Ruiz, Mario; Aguado, José María
- Abstract
We investigated the prognostic role of high MICs for antistaphylococcal agents in patients with methicillin-sensitive Staphylococcus aureus catheter-related bloodstream infection (MSSA CRBSI). We prospectively reviewed 83 episodes from 5 centers in Spain during April 2011-June 2014 that had optimized clinical management and analyzed the relationship between E-test MICs for vancomycin, daptomycin, oxacillin, and linezolid and development of complicated bacteremia by using multivariate analysis. Complicated MSSA CRBSI occurred in 26 (31.3%) patients; MICs for vancomycin and daptomycin were higher in these patients (optimal cutoff values for predictive accuracy = 1.5 μg/mL and 0.5 μg/mL). High MICs for vancomycin (hazard ratio 2.4, 95% CI 1.2-5.5) and daptomycin (hazard ratio 2.4, 95% CI 1.1-5.9) were independent risk factors for development of complicated MSSA CRBSI. Our data suggest that patients with MSSA CRBSI caused by strains that have high MICs for vancomycin or daptomycin are at increased risk for complications.
- Subjects
SPAIN; MOLECULAR integrated circuits; VANCOMYCIN; CATHETER-related infections; METHICILLIN-resistant staphylococcus aureus; PROGNOSIS; BACTEREMIA; ANTIBIOTICS; COMPARATIVE studies; DRUG resistance in microorganisms; RESEARCH methodology; MEDICAL cooperation; MICROBIAL sensitivity tests; PEPTIDE antibiotics; RESEARCH; STAPHYLOCOCCAL diseases; DISEASE management; COMORBIDITY; EVALUATION research; TREATMENT effectiveness; KAPLAN-Meier estimator; PHARMACODYNAMICS; THERAPEUTICS
- Publication
Emerging Infectious Diseases, 2016, Vol 22, Issue 6, p1057
- ISSN
1080-6040
- Publication type
journal article
- DOI
10.3201/eid2206.151709